Illumina Ventures — 2022 Investments
4 investments dated 2022 · listed companies and verified rows first · show all
NuCicer develops improved crop varieties through selective breeding, starting with high-protein chickpeas designed for better nutrition.
AgTechAI & Machine LearningFoodTechDavis, US
Kathryn Cook(Executive Officer, Director)inDouglas Cook(Executive Officer, Director)
BoardPaimun Amini(Director)inJerry Steiner(Director)inCarsten Boers(Director)in
Co-investorsBetter Ventures Central LlcBlue Horizon CorporationLever VCRhapsody Venture PartnersStray Dog CapitalTrellis Road I Fund AB+1 more
Protillion Biosciences develops platform technology for antibody engineering and drug discovery.
AI & Machine LearningBiotechDeep TechCarlsbad, US
Curtis Layton(CEO/Co-Founder)inDavid Walt(Co-Founder)inWill Greenleaf(Co-Founder)inRobert Hollingsworth(Chief Scientific Officer)in
BoardSean Kendall(Director)inMalek Faham(Director)in
Co-investorsARCH Venture PartnersMerck Global Health Innovation FundMSD Global Health Innovation Fund
Santa Clara, US
Jekwan Ryu(Executive Officer, Director)Ronald M. Cook(Director)Eric Williams(Executive Officer)Tae Hoon Nahm(Director)
BoardTom Willis(Director, Executive Officer)in
Co-investorsWestern Technology Investment
The company develops diagnostics and biological sample collection devices, including a rapid sickle-cell test, supporting infectious disease detection and genomic, metabolomic, and microbiome research.
BiotechHealthtechMedical DevicesCambridge, US
Rahul Dhanda(Executive Officer, Director)inJames Collins(Director)David Walt(Director)in
BoardIssi Rozen(Director)in
Co-investorsCatalio Capital Management, LPGaingelsCatalio Capital ManagementGood VenturesGV (Google Ventures)Northpond Ventures+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.





.png)

















__Twitter.png)
